Skip to main content

On Demand ARC webinar: Inhaler technique optimisation and adherence through patient partnership

Use of technology, coaching of soft skills and how medicine reviews can help with this

In association with Sandoz, we are delighted to be hosting a new webinar series on asthma care

Inhaler technique optimisation and adherence through patient partnership: use of technology, coaching of soft skills and how medicine reviews can help with this

In the final webinar in this new ARC series, Darush Attar-Zadeh will discuss how improving patient engagement through health promotion, prevention strategies, education and empowerment are key steps to improving the quality of outcomes for patients and increasing adherence to long-term therapies. This talk will focus on using technology to support inhaler technique, self-management plans, reducing harm associated with inappropriate prescribing and utilising the wider healthcare workforce including community pharmacies.

This non-promotional webinar has been sponsored by Sandoz who have had no editorial input into the presentation. At the end of the webinar, there will be a short promotional session from Sandoz.


Speaker: Darush Attar-Zadeh

A pharmacist based in the community and primary care; specialising in the field of treating tobacco dependency and AsthmaRightCare. Darush has presented at various national & international conferences (including the PCRS, IPCRG, ERS, Clinical Pharmacy Congress). Darush was part of the London Clinical Senate Helping Smokers Quit programme. In his role as respiratory lead pharmacist (Barnet CCG & RightBreathe), Darush managed to lead a medicines management service to winning the pharmacist award in respiratory services 2016. In 2019 Darush was awarded PCPA GP Pharmacist runner up, recognised for pharmacological/non-pharmacological interventions. He runs group sessions with patients and clinicians.
Darush enjoys running and raising money for respiratory & cardiac charities. One of his main missions is to reduce health inequalities caused by tobacco and spends a lot of his time teaching in deprived locations across the UK.

Chair: Fiona Mosgrove

I qualified as GP in 2012 and have worked in a variety of practices since then.  The last few years has seen my develop a passion for respiratory medicine.   I currently work in a busy inner city practice with a high prevalence of respiratory disease, in association with a deprived population.  I am also a senior clinical lecturer with the General Practice team at the University of Aberdeen and have a clinical lead role focused on improving respiratory outcomes for high risk patients.  I am delighted to become part of the wider respiratory community and to begin contributing to improving respiratory education for my colleagues.  


Sandoz, a division of the Novartis Group, has been in the respiratory market in the UK for the last 7 years. As part of their commitment to the respiratory therapy area, they continue to invest in improving asthma care by supporting education for healthcare professionals.